| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9974586 | The Journal of Heart and Lung Transplantation | 2005 | 11 Pages |
Abstract
Although both agents proved effective to prevent OAD development, histology revealed major differences. The anti-proliferative potency of FK778 on SMC may be an important mechanism of action. Combination regimens showed favorable drug interaction and allowed dose reduction of both agents to achieve maximal immunosuppressive efficacy.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Tobias MD, Sonja MD, Friedrich MD, PhD, Munif MD, Edzard MD, Rainer MD, PhD, Hansjörg MD, PhD, Christian MD, Hermann MD, PhD,